Perampanel add‐on vs placebo
Proportion of participants who experienced ≥ 1 adverse effect · people (aged 12 years and over) with drug‐resistant focal epilepsy
Perampanel add‐on leads to higher proportion of participants who experienced ≥ 1 adverse effect compared with placebo (high certainty).
1 finding from 1 review
- RR 1.17 [1.1, 1.24]7 studies · 2524 participantsHigh